Episode Details

New research reveals GLP-1 drugs like Ozempic and Wegovy slash heart attack and stroke risk by 20%—a game-changing benefit beyond weight loss. Studying 25,000 patients over three years, scientists found consistent results across ages and ethnicities, suggesting real cardiovascular protection. These drugs may now be pivotal for diabetics with heart disease—and even for overweight individuals without diabetes who’re at risk. While cost and side effects remain hurdles, the potential to prevent heart events could reshape treatment. Researchers are still unraveling how exactly these meds work—but this could be a major public health turning point.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/88570eb5e5867d05